NEWS
UK Biobank’s new HQ celebrates topping out
The new headquarters of UK Biobank, a £60 million state-of-the- art laboratory and innovation hub at Manchester Science Park called Greenheys, recently celebrated an important milestone, ‘topping out’ the new building. Greenheys will also be home to an accompanying hub for scaling businesses looking to collaborate with the large-scale biomedical database and research resource company.
The latest milestone marks a significant step forward for UK Biobank and Bruntwood SciTech. The new hub will provide much-needed, specialist laboratory and workspace in Manchester’s knowledge quarter within Europe’s largest clinical academic campus, and immediately neighbouring The University of Manchester. Greenheys will provide 131,000 square feet of workspace across six floors, with spaces ranging from 2,500 sq ft bespoke suites to 22,000 sq ft whole floorplates, including specialist CL2 labs. Having reached this important milestone, the project is due to complete in summer 2026.
UK Biobank is the world’s most
comprehensive source of biomedical data available for health research in the public interest. Its laboratory space will boast cutting-edge facilities, including a latest-generation robotic freezer capable of storing and retrieving up to 20 million biological samples four times faster than current standards, revolutionising the pace of scientific discovery. The relocation will dramatically increase the speed at which UK Biobank can supply samples to researchers, allow for the storage of millions more samples as UK Biobank expands, and be more environmentally efficient.
Digital partnership at North Bristol
North Bristol NHS Trust and Fujifilm Healthcare Europe are to continue their long-standing relationship, with the establishment of a reference site agreement for the UK featuring the Synapse Pathology solution to support Bristol’s innovative histology practice. This will be Fujifilm Healthcare Europe’s
first reference site for SYNAPSE Pathology and Synapse Pathology Gateway across Europe. This partnership underscores a commitment to advancing digital pathology practices and improving patient care through innovative diagnostic technologies.
The partnership first began in February 2022 and has continued to grow, supporting North Bristol NHS Trust in its implementation of digital pathology to meet the ever-growing NHS turnaround targets. As part of the reference site agreement, Bristol will continue to partner with Fujifilm to assist in the development of the Synapse Pathology solution offering. This includes
adoption of new related solutions such as Synapse Pathology Gateway – a modular offering that has enabled Bristol to implement data analytics, IMS reporting and AI functionality (in partnership with IBEX Medical Analytics) and digitalised automatic outsourcing of whole slide images with Source LDPath. The Cellular Pathology Department at North Bristol NHS Trust receives cases from NBT and University Hospitals Bristol and Weston NHS Foundation Trust, with all histology samples processed at the NBT site. The main histology laboratory currently utilises eight Hamamatsu slide scanners and outputs more than 500,000 slides per annum. “We are thrilled to continue our collaboration with FUJIFILM Healthcare as a reference site for the Synapse Pathology solution, which will continue to significantly enhance our diagnostic capabilities, output, and patient care,” commented Mark Orrell, Operations Manager for Cellular Pathology at North Bristol NHS Trust.
WWW.PATHOLOGYINPRACTICE.COM JUNE 2025 9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
